MedTrace Logo

Efficacy of Chemoradiotherapy After Neoadjuvant Cisplatin and Docetaxel in the Nasopharynx Carcinoma

NCT00772681 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 57

Last updated 2009-12-07

No results posted yet for this study

Summary

* To assess the efficacy of docetaxel, cisplatin combination in terms of disease free survival.
* Time to progression of the disease in terms of local and distant failure; assess the survival time, and assess the objective (clinical and radiological) response rate and the safety of the treatment.

Conditions

  • Head and Neck Neoplasms

Interventions

DRUG

docetaxel and cisplatin

3 cycles of docetaxel 75mg/m2 and 100mg/m2 cisplatin combination every 3 weeks

Sponsors & Collaborators

Principal Investigators

  • Edibe Taylan, MD · Sanofi

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-10-31
Primary Completion
2008-03-31
Completion
2008-03-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00772681 on ClinicalTrials.gov